Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy

OBJECTIVE: Erythropoietin (EPO) may be protective for early stage diabetic retinopathy, although there are concerns that it could exacerbate retinal angiogenesis and thrombosis. A peptide based on the EPO helix-B domain (helix B-surface peptide [pHBSP]) is nonerythrogenic but retains tissue-protecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: McVicar, Carmel M., Hamilton, Ross, Colhoun, Liza M., Gardiner, Tom A., Brines, Michael, Cerami, Anthony, Stitt, Alan W.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Diabetes Association 2011
Materias:
Complications
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3198080/
https://ncbi.nlm.nih.gov/pubmed/21911748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db11-0026
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares